Skip to main content

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) Investor Securities Class Action Lawsuit 06/05/2024

  • If you purchased a significant amount of shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) between March 17, 2021 and May 7, 2024, and / or if you purchased any NASDAQ: MRNS shares prior to March 2021 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: August 5, 2024. NASDAQ: MRNS investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

June 05, 2024 - An investor in shares of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by Marinus Pharmaceuticals, Inc. in connection with certain allegedly false and misleading statements made between March 17, 2021 and May 7, 2024. Radnor, PA based Ma...

You must register (for free) or login to view the entire case.